Pre-IPO

7.7% Below IPO Floor Price, Global New Material's Low Offer Price Reveals Its Ambition to be Global Leader

Thursday, July 15, 2021 - 10:00am

On July 9, Global New Material (stock code: 6616) announced an IPO price of HKD3.25, 7.67% lower than the previous IPO floor price.

Key Points: 
  • On July 9, Global New Material (stock code: 6616) announced an IPO price of HKD3.25, 7.67% lower than the previous IPO floor price.
  • From the investors' perspective, Global New Material lowering its IPO price from that of the IPO period, in fact, has left more room for market share price appreciation in the future.
  • In fact, Global New Material lowering its IPO price is probably not only for this purpose.
  • Backed by strong R&D, Global New Material can launch over 100 new products each year, leading the global industry.

Standigm Secures $10 M From Pavilion Capital to Accelerate Its Global Competitiveness

Tuesday, July 6, 2021 - 1:00pm

Standigm Inc. (Standigm), the leading workflow artificial intelligence (AI) drug discovery company, announced today that they have secured a $10 million investment from Pavilion Capital, a Singapore-based investment institution.

Key Points: 
  • Standigm Inc. (Standigm), the leading workflow artificial intelligence (AI) drug discovery company, announced today that they have secured a $10 million investment from Pavilion Capital, a Singapore-based investment institution.
  • Standigm states that the investment will be used for the clinical research of AI-driven drug compounds to strengthen the companys competitiveness in the global market.
  • Pavilion Capital focuses on private equity and venture capital funds and direct investments in companies that ride on the growth and transformation of the North Asia and Southeast Asia economies.
  • Meanwhile, Standigm has recently completed a series of investments from SK Chemicals and Pavilion Capital after its Pre-IPO funding in March , confirming high expectations for its successful IPO.

Medigus: Eventer Technologies Submitted Public Prospectus for an IPO on the Tel Aviv Stock Exchange

Thursday, June 3, 2021 - 2:00pm

In April 2021, Eventer successfully completed a pre-IPO funding round of $2.25 million.

Key Points: 
  • In April 2021, Eventer successfully completed a pre-IPO funding round of $2.25 million.
  • The funding round included an investment of $1.5 million from Keshet, a leading Israeli broadcasting and media group.
  • Medigus invested eight months ago $750,000 in Eventer for 58.77% of the company.
  • Other risk factors affecting Medigus and Eventer are discussed in detail in the Medigus filings with the Securities and Exchange Commission.

iVvy Announces AUD$7m (U.S. $5.4m) pre-IPO Investment Round to Accelerate Global Growth

Thursday, May 20, 2021 - 11:00am

iVvy plans to list on the Australian Securities Exchange within the next 12 months.\nThe pre-IPO round was led by Thorney Investment Group, one of Australia\'s most successful private investment groups, and Gandel Invest, led by Tony Gandel.

Key Points: 
  • iVvy plans to list on the Australian Securities Exchange within the next 12 months.\nThe pre-IPO round was led by Thorney Investment Group, one of Australia\'s most successful private investment groups, and Gandel Invest, led by Tony Gandel.
  • Both firms are deeply experienced in supporting visionary SaaS entrepreneurs to build category dominating companies that disrupt industries ripe for change.
  • Melbourne-based Cannacord Genuity served as financial advisor to iVvy in the transaction.
  • iVvy offers meeting planners the ability to search, compare, book and pay for function space, catering and group accommodations online, 24/7.

Worldwide Initial Public Offering Service: Stay Ahead of the Game With Initial Public Offering (IPO) Data - ResearchAndMarkets.com

Thursday, March 18, 2021 - 3:54pm

The "Worldwide Initial Public Offering" database has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Worldwide Initial Public Offering" database has been added to ResearchAndMarkets.com's offering.
  • The Worldwide Initial Public Offering monitors IPOs using local stock exchanges as the primary source of information, along with additional secondary sources such as international news agencies as confirmation.
  • Announcements are captured at six different stages:
    New - indicates that the IPO is complete (or in action) and the listing date is today or yesterday.
  • Historical - indicates that the IPO has taken place and the listing date is more than 2 days before.

Standigm Secures $44.5 M in Pre-IPO Funding Round

Friday, March 5, 2021 - 1:00pm

Standigm Inc. (Standigm), a leading Korean Artificial Intelligence (AI) company for drug discovery, announces today that it has closed $44.5 million in a pre-IPO funding round co-led by SKS PE and Daishin Private Equity.

Key Points: 
  • Standigm Inc. (Standigm), a leading Korean Artificial Intelligence (AI) company for drug discovery, announces today that it has closed $44.5 million in a pre-IPO funding round co-led by SKS PE and Daishin Private Equity.
  • The closing marks the last round of funding before Standigm goes to its planned initial public offering (IPO) on the Korea Exchange (KRX) later this year.
  • The fund in this round will be used to bolster business-to-business sales through our advanced platform technology, said Jinhan Kim, co-founder and CEO of Standigm.
  • Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactory, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASK for target discovery, Standigm BEST for lead selection, and Standigm Insight for drug repurposing.

Keith Abramson joins ElectroNeek as VP of Sales

Tuesday, January 26, 2021 - 7:28pm

NEW YORK, Jan. 26, 2021 /PRNewswire/ -- ElectroNeek, recently named one of the RPA Momentum Market Leaders by G2, today announced that it has hired Keith Abramson as Global VP of Sales.

Key Points: 
  • NEW YORK, Jan. 26, 2021 /PRNewswire/ -- ElectroNeek, recently named one of the RPA Momentum Market Leaders by G2, today announced that it has hired Keith Abramson as Global VP of Sales.
  • With over 11 years of sales leadership experience in early-stage SaaS startups, Keith has deep experience in both the creation and execution of hypergrowth sales strategies.
  • Prior to joining Electroneek, Keith held early-stage leadership roles in Tufin (IPO - $450M), Darktrace (Pre-IPO, $2B), and Kyriba (Acquired - $1B).
  • ElectroNeek, with its novel developer UX and one-of-a-kind licensing model, has been already dubbed as the global RPA market disruptor.

XPeng Inks Strategic Cooperation Agreement with Banks for RMB12.8 Billion Credit Facilities

Tuesday, January 12, 2021 - 3:45am

XPeng Inc. (XPeng or the Company, NYSE: XPEV), a leading Chinese smart electric vehicle (Smart EV) company, announced it signed a strategic cooperation agreement with leading domestic banks at a signing ceremony held today in Guangzhou, China, pursuant to which it will secure a credit line of RMB12.8 billion with an extensive range of credit facilities (the Agreement).

Key Points: 
  • XPeng Inc. (XPeng or the Company, NYSE: XPEV), a leading Chinese smart electric vehicle (Smart EV) company, announced it signed a strategic cooperation agreement with leading domestic banks at a signing ceremony held today in Guangzhou, China, pursuant to which it will secure a credit line of RMB12.8 billion with an extensive range of credit facilities (the Agreement).
  • These facilities will help the Company optimize the efficiency of its cash management, cost control and other corporate functions.
  • The strategic cooperation with leading banks further diversifies The Companys funding channels, underscoring its solid business fundamentals and growth prospects.
  • The Company is developing rapidly following its successful $900 million pre-IPO fundraising and $1.7 billion IPO in August 2020.

Phoenix PharmaLabs Announces New Investment Offering with Netcapital

Monday, December 21, 2020 - 3:00pm

Phoenix PharmaLabs, a privately held, preclinical drug company dedicated to developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced it has launched its second offering campaign on the Netcapital platform: https://netcapital.com/companies/phoenix .

Key Points: 
  • Phoenix PharmaLabs, a privately held, preclinical drug company dedicated to developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced it has launched its second offering campaign on the Netcapital platform: https://netcapital.com/companies/phoenix .
  • Phoenix PharmaLabs raised more than one million dollars in 2019 through an oversubscribed offering via the Netcapital platform, with hundreds of investors participating in the opportunity.
  • Bill Crossman, CEO of Phoenix PharmaLabs, said, The need for effective treatment of moderate-to-severe pain without risk of addiction or overdose continues to be unmet.
  • The company offers investor access to pre-IPO investment opportunities as well as potential liquidity in privately held shares via a Secondary Transfer Platform, provided by Netcapital Systems.

Unicorns.show Will Provide Scalable Startups With Access To Millions of Investors; Seeks Contenders

Thursday, December 17, 2020 - 7:05pm

Unicorns.show is the beginning of a new genre - enrichtainment: programming that gives audience members the opportunity to become richer, instead of just being entertained."

Key Points: 
  • Unicorns.show is the beginning of a new genre - enrichtainment: programming that gives audience members the opportunity to become richer, instead of just being entertained."
  • The show will give priority to companies who have received venture capital funding or had their high-growth potential validated in other ways.
  • "Pre-IPO investing involves the risk of a total investment loss and the chance of seeing a hundred thousand percent returns.
  • Our job is to offer the audience the ability to invest in the emerging growth companies most likely to succeed."